Recent comments
-
Episode 156: PREMIUM Injecting common sense into painful problems
Would you strongly encourage an elderly patient to take a PPI if prescribing a NSAID for OA? Was this accounted for in the cohort trial?
- Episode 126: Questions from near and far and answers from way out - Part II
-
Episode 130: Getting exorcised about the evidence around exercise
Interesting infotmation, thanks!
purchase viagra online order viagra buy cialis online sorry :( -
Episode 152: Leaking out the evidence around overactive bladders and urge incontinence
Hi there .
Love your podcasts.
I am interested whether Mike's statement that caffeine is a bladder irritant is valid though? What is the evidence base for this? Is the urinary frequency simply indicative of the volume of liquid taken when drinking coffee or is it the fairy dust effect of coffee on the transitional epithelium of the bladder?
Many Thanks,
Mick Tarry -
Episode 150: Respecting frailty in a cognitive way
Thanks for a thoughtful approach to this issue.
-
Episode 152: Leaking out the evidence around overactive bladders and urge incontinence
Hi Jim or James :) - It is great to here that something we have done has got you excited about evidence again - we hear from so many people that incorporating evidence and patient preferences into practice brings back the art of medicine. It's a heck of a lot more rewarding.
-
Episode 151: PREMIUM Aiming high and long with two studies that should impact practice
Hi Paul - glad you found the studies useful - PREMIUM unfortunately tpically means yet another study showing things don't work as well as we thought. This info is definitely PREMIUM for those patients on these medications. Thanks.
-
Episode 152: Leaking out the evidence around overactive bladders and urge incontinence
James and Mike (or Mike and James?)
Thanks for the way you tackle the trials. You got me excited about evidence based medicine again and I am glad I am now a premium member. I saw you guys in Illinois a couple of years ago at VA program and have been listening to podcasts since.
Thanks!!! Jim
-
Episode 151: PREMIUM Aiming high and long with two studies that should impact practice
Both interesting studies; it's refreshing to review clinical trials which find no useful clinical benefit with a common treatment...or no better benefit with longer use. That's what Premium's all about.
I'm glad James & Mike linked to the BMJ analysis "Idolatry of the Surrogate" (Yudkin and Montori), but was crestfallen when I discovered the full-text was behind a paywall. Wish I were a hacker.
Have never ever prescribed zoledronic for anyone. Now I can start using gallons of the stuff...but only for 3 years. And not in postmenopausal men.
Paul
-
Episode 148: Definitively vague questions with vaguely definitive answers - PART II
Hi Melanie - sorry I missed that one. The reference is
Vitamin B for 4.7 years lowered homocysteine and had no effect on overall cardiovascular events. It actually increased mortality by 2.2%.
-
Episode 148: Definitively vague questions with vaguely definitive answers - PART II
In this podcast, Mike mentioned Tina had recently reviewed a study showing harms of vitamin B12. Can you please post the reference? I couldn't find it on your show notes list.
Melanie
-
Episode 148: Definitively vague questions with vaguely definitive answers - PART II
Hi Lea - our pleasure - it comes easy - except the irreverent part which we really have to work at. :)
-
Episode 148: Definitively vague questions with vaguely definitive answers - PART II
Thanks Mike and James,
Clear, educational, irreverent and useful.
Lea -
Episode 149: Definitively vague questions with vaguely definitive answers - PART III
Hi Karen - according to the study "more bread, more root vegetables and green vegetables, more fish, less meat (beef, lamb, and pork to be replaced with poultry), no day without fruit, and butter and cream to be replaced with margarine supplied by the study. Because the patients would not accept olive oil-traditional to the Mediterranean diet-as the only fat, a rapeseed (canola) oil-based margarine was supplied free. The oils recommended for salads and food preparation were rapeseed and olive oils exclusively. Moderate alcohol consumption in the form of wine was allowed at meals"
Sounds very tasty to me - except I like butter.
-
Episode 149: Definitively vague questions with vaguely definitive answers - PART III
Hi! I am wondering what the mediterranean diet was in the studies that showed cardiovascular risk reduction.
Thanks.
-
Episode 147: Definitively vague questions with vaguely definitive answers
Making sure our students are educated and competent is our primary role as teachers. We try to pass on the core elements of the topics and we try hard to provide appropriate knowledge and skills. We ultimately do this not just for our students, but for the public our students will ultimately care for. Captivating students to enhance their learning, without distracting from the content, can often be a useful tool. There are all sorts of ways to captivate students - they range from fear of exams to humour and all in between. In these circumstances, many programs have found games, educational exercises and at times humour, to be helpful. Hope that helps and we just try to do the best we can.
-
Episode 147: Definitively vague questions with vaguely definitive answers
There are requirements in the world of which fun is not one of them. Educators have been evading anything actually academic for some time now.
Kinda hard making with the yuks when your university program thinks powerpoints=lectures, lecturers=comedians and the student who footed the bill comes out incompetent and unprepared to address patient concerns and questions
-
Episode 117: The mind boggles and the heart goes all a flutter
Have you heard of spacing the time of the ACEI and the beta blocker by 2 hours.
-
Episode 144: A heads-up look at the prevention of headaches - Part II
Hi Ralf - great question - first off it's important to realise the difference between the placebo effect and what happens in the placebo group. The big chunk of the 20% success is not the placebo effect but "tincture of time". Personally I feel their are too many ethical dilemmas to use placebos outside of clinical trials but I think the best way around the issue is to start with very low doses - 1/4 to an 1/8 of the normal dose - that way you can avoid many of the side effects and still get the effect of doing something (placebo?) and also the effect of the very low dose. Check out our paper in CMAJ on the low dose issue. CMAJ 2011;183:65–9
-
Episode 144: A heads-up look at the prevention of headaches - Part II
Particularly in pain and insomnia placebo often has a success-rate of upwards of 20% and in other fields a NNT of 5 would be quite spectacular. But we are not supposed to lie to patients and therefore the use of placebo is frowned upon.
Is it ethically better to prescribe a (possibly expensive) medication with possible side effects in the full knowledge that it will probably work no better than placebo, rather than a cheap and harmless placebo tablet? And yes, I know that placebos have side effects too.
Please discussLove the show
Ralf -
Episode 138: Seeing right through the evidence for the risk of CT scans
good info to share with patients
-
Episode 135: Antipsychotics - use in the elderly - part 4
Hi Sue - thanks - glad you enjoy the podcast - I'll fire this off to Mike and add it to our "evidence" pile
-
Episode 135: Antipsychotics - use in the elderly - part 4
Hi Mike and James
really love you podcast. I learn lots and also laugh along with you.
So not sure if this is the same study as the note above...I get daily POEMS (recommended by you Mike) by email. Just got one about study in Norwegian nursing home that was in BMJ. They found that "A systematic approach to the management of pain significantly reduced agitation in residents of nursing homes with moderate to severe dementia. Effective management of pain can play an important part in the treatment of agitation and could reduce the number of unnecessary prescriptions for psychotropic drugs in this population."
thanks
Sue -
Episode 135: Antipsychotics - use in the elderly - part 4
Hi Mike & James,
Love the podcast...find it great listening in the car on the way to work!
Sure you've come across this study already (http://www.npc.nhs.uk/rapidreview/?p=4119), would seem that patient pain is definitely worth close consideration in terms of the potential positive impact of its treatment on adverse behavioural aspects of dementia and the fact that paracetamol, one of the relatively safer drug interventions in the patient population most affected (the frail elderly), can be effective!
-
Episode 134: Antipsychotics - schizophrenia the drugs - part 3
Hi: Last year we put a lot of time and money into accrediting the podcasts here in Canada (MDs and Rx's) and for physicians, Canada and the States have education reciprocity. We charged $10 per one hour credit and we had almost no uptake. For that reason we took that page down a few weeks ago. If you have any thoughts about how we could do this differently please let me know.

"Osteoarthritis and NSAIDs" in reply to: Episode 156: PREMIUM Injecting common sense into painful problems
"1" in reply to: Episode 126: Questions from near and far and answers from way out - Part II
"Interesting infotmation," in reply to: Episode 130: Getting exorcised about the evidence around exercise